Statera BioPharma Inc (STAB)
0.0007
0.00 (0.00%)
USD |
OTCM |
Apr 29, 16:00
Statera BioPharma Cash from Investing (TTM): -0.1034M for Sept. 30, 2022
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2022 | -0.1034M |
| June 30, 2022 | 12.94M |
| Date | Value |
|---|---|
| March 31, 2022 | 13.46M |
| December 31, 2021 | 13.46M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.1034M
Minimum
Sep 2022
13.46M
Maximum
Dec 2021
9.941M
Average
13.20M
Median
Cash from Investing (TTM) Benchmarks
| Cantabio Pharmaceuticals Inc | -- |
| Q BioMed Inc | -- |
| NVN Liquidation Inc | -5.961M |
| Affymax Inc | -- |
| Scopus BioPharma Inc | 0.00 |